This is especially important for individuals with diabetes, as any supplement claiming metabolic effects requires medical oversight to ensure it does not interfere with established treatment regimens or mask concerning symptoms requiring evaluation
GLP-1 innovation vector (5): Cost and coverage As noted above, employers and payers are increasingly grappling with how much GLP-1 coverage they can sustain
The risk of pancreatitis associated with GLP-1 receptor agonists warrants particular attention in patients with heavy alcohol consumption, as chronic alcohol use is itself a significant risk factor for both acute and chronic pancreatitis
These patients may also respond better to traditional immunosuppressive treatments, further supporting the connection between metabolic health and autoimmune inflammation
Effects of the novel long-acting GLP-1 agonist, albiglutide, on cardiac function, cardiac metabolism, and exercise capacity in patients with chronic heart failure and reduced ejection fraction
Anti-inflammatory effects of GLP-1 Beyond weight loss, GLP-1 medications directly combat joint inflammation
